Systematic integration of biomedical knowledge prioritizes drugs for repurposing - Archive ouverte HAL Access content directly
Journal Articles eLife Year : 2017

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

(1, 2) , (3, 4) , (4) , (4, 5) , (4, 6) , (7, 8) , (4) , (4, 9) , (1, 4)
1
2
3
4
5
6
7
8
9

Abstract

The ability to computationally predict whether a compound treats a disease would improve the economy and success rate of drug approval. This study describes Project Rephetio to systematically model drug efficacy based on 755 existing treatments. First, we constructed Hetionet (neo4j.het.io), an integrative network encoding knowledge from millions of biomedical studies. Hetionet v1.0 consists of 47,031 nodes of 11 types and 2,250,197 relationships of 24 types. Data were integrated from 29 public resources to connect compounds, diseases, genes, anatomies, pathways, biological processes, molecular functions, cellular components, pharmacologic classes, side effects, and symptoms. Next, we identified network patterns that distinguish treatments from non-treatments. Then, we predicted the probability of treatment for 209,168 compound-disease pairs (het.io/repurpose). Our predictions validated on two external sets of treatment and provided pharmacological insights on epilepsy, suggesting they will help prioritize drug repurposing candidates. This study was entirely open and received realtime feedback from 40 community members.
Fichier principal
Vignette du fichier
elife-26726.pdf (5.06 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-02154787 , version 1 (13-06-2019)

Identifiers

  • HAL Id : inserm-02154787 , version 1

Cite

Daniel Scott Himmelstein, Antoine Lizee, Christine Hessler, Leo Brueggeman, Sabrina L Chen, et al.. Systematic integration of biomedical knowledge prioritizes drugs for repurposing. eLife, 2017. ⟨inserm-02154787⟩
209 View
125 Download

Share

Gmail Facebook Twitter LinkedIn More